Firstly Kruse and Kuhlencordt in 1975 [241], in patients with primary and secondary osteoporosis treated with GH, reported an increase in periosteal new bone formation and an intracortical bone resorption with a significantly increased relative osteoblast activity. This evidence concerns the gene GH1 and osteoporosis.